Why the study?
Does endomyocardial biopsy provide diagnostic information in symptomatic infants and children with cardiomyopathy?
Does endomyocardial biopsy provide diagnostic information in symptomatic infants and children with cardiomyopathy?
Endomyocardial biopsy in pediatric cardiomyopathy has a low positive diagnostic yield and carries procedural risks, but may provide crucial diagnostic information in selected cases.
Answers are grounded in this paper and cite their sources.
Low yield with perforation risk limits routine pediatric endomyocardial biopsy; leaves open selective diagnostic role in cardiomyopathy.
We reviewed our experience of endomyocardial biopsy performed on 21 symptomatic infants and children with cardiomyopathy. Clinical congestive cardiomyopathy was noted in 18 patients, 2 had hypertrophic cardiomyopathy, and 1 a restrictive cardiomyopathy. The biopsy findings led to a diagnosis of hemochromatosis in one patient, Adriamycin cardiomyopathy in another, and lymphocytic myocarditis in a third. Five patients had features of endocardial fibroelastosis, one endomyocardial fibrosis, and a further one, a mitochrondrial abnormality. In 11 patients normal or nonspecific features were seen. There were 2 myocardial perforations, both patients being successfully resuscitated. Endomyocardial biopsy, although occasionally hazardous, may sometimes provide valuable information which may lead to a diagnosis, facilitate treatment, and be of prognostic value. Despite the low positive yield, it may still be indicated in selected patients, in view of the seriousness and often poor prognosis of this disorder: 5 of our study group subsequently died.
No takes yet. Share an insight, caveat, or question.
Narayan et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: